Target intelligence / Profile preview

Spectrin beta chain, erythrocytic (SPTB)

Target
SPTB
Molecular classification
Cytoskeletal protein, Structural protein, Membrane-associated protein, Scaffold protein
01

Overview

Spectrin beta chain, erythrocytic (SPTB) is a major cytoskeletal protein found primarily in red blood cells, where it forms heterotetramers with alpha-spectrin, interacting with other membrane proteins such as ankyrin and actin to maintain erythrocyte membrane stability and flexibility. Deficiencies or mutations in SPTB compromise membrane integrity and are clinically associated with hereditary spherocytosis, hereditary elliptocytosis, hereditary pyropoikilocytosis, and other hemolytic anemias, leading to abnormal erythrocyte morphology and increased cell fragility. The protein is not considered a therapeutic target, but its function is critical for erythrocyte health.

Other names
SPTBSPTB1Beta-I spectrinErythrocytic spectrin beta chainSpectrin beta chain, erythrocyticspherocytosis, clinical type IEL3HS2HSPTB1SPH2Sp betamembrane cytoskeletal proteinspectrin beta Tandilspectrin beta chain, erythrocyte
02

Mechanism of action

Not applicable (SPTB is not directly targeted by drugs)

03

Biological functions

Maintenance of membrane integrity and flexibility in erythrocytesCytoskeletal organizationCell membrane organization and stabilityCell shape maintenanceInteraction with actin and other cytoskeletal elements
04

Disease associations

Hereditary spherocytosisHereditary elliptocytosisHemolytic anemiaHereditary pyropoikilocytosis
05

Safety considerations

Mutations can lead to membrane fragility, causing hemolytic anemia and associated complications
06

Interacting drugs

None (no approved drugs directly target SPTB; disease management is supportive and targets downstream effects)
07

Biomarkers

Decreased SPTB protein/functon may serve as a biomarker for hereditary spherocytosis and related hemolytic anemias

Beyond the preview

Go deeper on Spectrin beta chain, erythrocytic (SPTB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spectrin beta chain, erythrocytic (SPTB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call